Bhartiya International Limited vs TTK Healthcare Limited
Last updated: 1 September 2026
Bhartiya International Ltd. vs. TTK Healthcare Ltd.: A MoneyDock Comparison
In the diverse landscape of Indian equities, investors often seek to compare companies across different sectors to identify potential opportunities. Today, we pit Bhartiya International Limited (BIL.NS), a prominent player primarily in the leather and fashion industry, against TTK Healthcare Limited (TTKHLTCARE.NS), a diversified healthcare and consumer products company. While their core operations differ significantly, both companies represent established entities in the Indian market, attracting investor interest. This comparison aims to provide a data-driven overview, utilizing the most recent available figures to help investors make informed decisions, despite the current lack of comprehensive market data for both firms.
Key Financial Metrics Comparison
| Metric | Bhartiya International Ltd. (BIL.NS) | TTK Healthcare Ltd. (TTKHLTCARE.NS) |
|---|---|---|
| Current Price | ₹885.45 | ₹1128.70 |
| 52-Week High | ₹N/A | ₹N/A |
| 52-Week Low | ₹N/A | ₹N/A |
| 1-Year Return | N/A% | N/A% |
| Trailing P/E | N/A | N/A |
| Market Cap | N/A | N/A |
Analysis: Valuation, Returns, and Stability
Given the limited data available, a comprehensive analysis of Bhartiya International Limited and TTK Healthcare Limited proves challenging. As per the provided figures, key metrics like 52-week high and low, 1-year return, trailing P/E, and market capitalization are all unavailable for both companies. This absence of data significantly restricts our ability to draw definitive conclusions regarding their valuation, historical performance, and overall stability.
Currently, TTK Healthcare Limited trades at a higher price point of ₹1128.70 compared to Bhartiya International Limited's ₹885.45. However, without P/E ratios or market capitalization figures, it is impossible to determine which company offers a better valuation. A higher share price does not necessarily indicate overvaluation, just as a lower price doesn't automatically imply a bargain. These figures merely represent the current trading price per share.
Regarding returns, both companies show 'N/A%' for their 1-Year Return. This means we cannot assess which company has delivered better historical performance over the past year or extrapolate any trends. Similarly, the lack of 52-week high and low prices prevents us from understanding their recent price volatility or range, which are crucial indicators of a stock's stability and risk profile.
In terms of stability, the absence of market capitalization data means we cannot compare their size or market presence. Generally, larger market capitalization companies tend to be more stable due to their scale and diversified operations, but this cannot be confirmed here. The lack of trailing P/E also hinders our ability to gauge investor sentiment and expectations regarding future earnings, which is a significant factor in assessing a company's financial health and stability.
In summary, with the currently available data, it is not feasible to declare a 'winner' in terms of valuation, returns, or stability between Bhartiya International Limited and TTK Healthcare Limited. Investors would need more comprehensive financial statements, historical price data, and fundamental analysis to make an informed comparison.
MoneyDock Verdict
For Aggressive Investors: With the current lack of critical data such as P/E ratios, market caps, and historical returns, neither stock presents a clear aggressive investment opportunity based solely on the provided numbers. Aggressive investors typically look for growth potential and may accept higher risk, but without fundamental data, assessing this risk or potential is impossible. Both are speculative without more information.
For Conservative Investors: Conservative investors prioritize capital preservation and stable returns. The absence of crucial metrics like P/E, 1-year return, and 52-week ranges makes it impossible to assess the stability or risk profile of either Bhartiya International Limited or TTK Healthcare Limited. Therefore, neither company can be recommended for a conservative portfolio at this time based on the limited data.
For Long-Term SIP Investors: Long-term SIP investors benefit from rupee-cost averaging and aim for consistent growth over time. However, without historical return data, valuation metrics, or an understanding of market capitalization, it is challenging to gauge the long-term potential or fundamental strength of either company. Investors interested in a long-term SIP in either stock would need to conduct thorough due diligence beyond these figures, delving into their business models, management quality, and future growth prospects.
Overall: Based on the provided data, which is largely incomplete, MoneyDock cannot provide a conclusive verdict or recommendation for either Bhartiya International Limited or TTK Healthcare Limited across any investor profile. Prospective investors are strongly advised to seek more comprehensive financial data and perform detailed fundamental and technical analysis before making any investment decisions. The current information is insufficient for a meaningful comparison or investment strategy.
Price data from Yahoo Finance. AI analysis by MoneyDock. Not financial advice — always do your own research before investing.